FullText URL fulltext.pdf
Author Kuribayashi, Tadahiro| Kinoshita, Rie| Ninomiya, Kiichiro| Makimoto, Go| Kubo, Toshio| Rai, Kammei| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| Toyooka, Shinichi| Sakaguchi, Masakiyo| Ohashi, Kadoaki|
Keywords S100A8/A9 Lung cancer Immune checkpoint inhibitors
Note The version of record of this article, first published in Scientific Reports, is available online at Publisher’s website: http://dx.doi.org/10.1038/s41598-025-87232-z|
Published Date 2025-01-20
Publication Title Scientific Reports
Volume volume15
Issue issue1
Publisher Nature Portfolio
Start Page 2577
ISSN 2045-2322
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2025
File Version publisher
PubMed ID 39833332
DOI 10.1038/s41598-025-87232-z
Web of Science KeyUT 001400880600002
Related Url isVersionOf https://doi.org/10.1038/s41598-025-87232-z
FullText URL fulltext.pdf
Author Inukai-Motokura, Yumi| Ninomiya, Kiichiro| Baba, Takahiro| Omori, Hiroki| Takeguchi, Tetsuya| Uno, Mari| Ayada, Yoshiyuki| Tanaka, Takehiro| Maeda, Yoshinobu| Ohashi, Kadoaki|
Keywords Pulmonary sclerosing pneumocytoma Ipilimumab Nivolumab Programmed cell death ligand 1 Case report
Published Date 2024-11-29
Publication Title International Cancer Conference Journal
Volume volume14
Issue issue1
Publisher Springer Science and Business Media LLC
Start Page 60
End Page 63
ISSN 2192-3183
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2024
File Version publisher
DOI 10.1007/s13691-024-00737-8
Web of Science KeyUT 001366705400001
Related Url isVersionOf https://doi.org/10.1007/s13691-024-00737-8
FullText URL fulltext.pdf
Author Matsuura, Hiroaki| Makimoto, Go| Oda, Naohiro| Ninomiya, Kiichiro| Higo, Hisao| Fujii, Masanori| Rai, Kammei| Ichihara, Eiki| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu|
Keywords NUT carcinoma BRD4-NUTM1 lung cancer alpha-fetoprotein (AFP) immune checkpoint inhibitor
Published Date 2024-10-01
Publication Title Internal Medicine
Volume volume63
Issue issue19
Publisher Japanese Society of Internal Medicine
Start Page 2655
End Page 2660
ISSN 0918-2918
NCID AA10827774
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2024 by The Japanese Society of Internal Medicine
File Version publisher
PubMed ID 38403772
DOI 10.2169/internalmedicine.2938-23
Web of Science KeyUT 001344217900013
Related Url isVersionOf https://doi.org/10.2169/internalmedicine.2938-23
FullText URL fulltext.pdf
Author Yamashita, Masahiro| Higo, Hisao| Fujii, Nobuharu| Matsumoto, Chiaki| Makimoto, Go| Ninomiya, Kiichiro| Fujii, Masanori| Rai, Kammei| Ichihara, Eiki| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Miyahara, Nobuaki|
Keywords Chimeric antigen receptor-T cell therapy Coronavirus disease 2019 Multidrug therapy Organizing pneumonia
Published Date 2024
Publication Title Respiratory Medicine Case Reports
Volume volume51
Publisher Elsevier
Start Page 102104
ISSN 2213-0071
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2024 The Authors.
File Version publisher
DOI 10.1016/j.rmcr.2024.102104
Web of Science KeyUT 001307936800001
Related Url isVersionOf https://doi.org/10.1016/j.rmcr.2024.102104
FullText URL fulltext20240531-01.pdf
Author Tanaka, Takaaki| Taoka, Masataka| Makimoto, Go| Ninomiya, Kiichiro| Higo, Hisao| Fujii, Masanori| Ichihara, Eiki| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu|
Keywords immune checkpoint inhibitor nivolumab ipilimumab cytokine release syndrome immune effector cell-associated neurotoxicity syndrome
Published Date 2024-05-01
Publication Title Internal Medicine
Volume volume63
Issue issue9
Publisher Japanese Society of Internal Medicine
Start Page 1261
End Page 1267
ISSN 0918-2918
NCID AA10827774
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2024 by The Japanese Society of Internal Medicine
File Version publisher
PubMed ID 37722894
DOI 10.2169/internalmedicine.2429-23
Web of Science KeyUT 001223220900001
Related Url isVersionOf https://doi.org/10.2169/internalmedicine.2429-23
FullText URL fulltext.pdf
Author Matsuura, Hiroaki| Higo, Hisao| Kuribayashi, Tadahiro| Tamaoki, Akihiko| Nakasuka, Takamasa| Uno, Mari| Makimoto, Go| Ninomiya, Kiichiro| Fujii, Masanori| Rai, Kammei| Ichihara, Eiki| Hotta, Katsuyuki| Miyahara, Nobuaki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| Ohashi, Kadoaki|
Keywords case report EGFR-mutated lung cancer osimertinib pulmonary tuberculosis rifampicin
Published Date 2024-05-02
Publication Title Thoracic Cancer
Volume volume15
Issue issue17
Publisher Wiley
Start Page 1390
End Page 1394
ISSN 1759-7706
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2024 The Authors.
File Version publisher
PubMed ID 38698706
DOI 10.1111/1759-7714.15324
Web of Science KeyUT 001216948400001
Related Url isVersionOf https://doi.org/10.1111/1759-7714.15324
FullText URL fulltext.pdf
Author Hara, Naofumi| Ichihara, Eiki| Kano, Hirohisa| Ando, Chihiro| Morita, Ayako| Nishi, Tatsuya| Okawa, Sachi| Nakasuka, Takamasa| Hirabae, Atsuko| Abe, Masaya| Asada, Noboru| Ninomiya, Kiichiro| Makimoto, Go| Fujii, Masanori| Kubo, Toshio| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki|
Keywords Epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC) cell cycle CDK4/6 inhibitor
Published Date 2023-10-31
Publication Title Translational Lung Cancer Research
Volume volume12
Issue issue10
Publisher AME Publishing Company
ISSN 2218-6751
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © Translational Lung Cancer Research.
File Version publisher
PubMed ID 38025818
DOI 10.21037/tlcr-23-99
Web of Science KeyUT 001091030600001
Related Url isVersionOf https://doi.org/10.21037/tlcr-23-99
FullText URL fulltext20240226-04.pdf
Author Kuribayashi, Tadahiro| Ohashi, Kadoaki| Nishii, Kazuya| Ninomiya, Kiichiro| Tsubata, Yukari| Ishikawa, Nobuhisa| Kodani, Masahiro| Kanaji, Nobuhiro| Yamasaki, Masahiro| Fujitaka, Kazunori| Kuyama, Shoichi| Takigawa, Nagio| Fujimoto, Nobukazu| Kubota, Tetsuya| Inoue, Masaaki| Fujiwara, Keiichi| Harita, Shingo| Takata, Ichiro| Takada, Kenji| Okawa, Sachi| Kiura, Katsuyuki| Hotta, Katsuyuki|
Keywords EGFR EGFR-TKI Lung cancer Immune checkpoint inhibitors Performance status
Note The version of record of this article, first published in Journal of Cancer Research and Clinical Oncology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s00432-024-05618-4|
Published Date 2024-02-12
Publication Title Journal of Cancer Research and Clinical Oncology
Volume volume150
Issue issue2
Publisher Springer Science and Business Media LLC
Start Page 89
ISSN 1432-1335
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2024
File Version publisher
PubMed ID 38347279
DOI 10.1007/s00432-024-05618-4
Web of Science KeyUT 001160773600002
Related Url isVersionOf https://doi.org/10.1007/s00432-024-05618-4
FullText URL fulltext.pdf
Author Taoka, Masataka| Makimoto, Go| Umakoshi, Noriyuki| Ninomiya, Kiichiro| Higo, Hisao| Kato, Yuka| Fujii, Masanori| Kubo, Toshio| Ichihara, Eiki| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki|
Keywords Hemoptysis Bronchial artery embolization Endoscopic bronchial occlusion Endobronchial Watanabe Spigot
Published Date 2022
Publication Title Respiratory Medicine Case Reports
Volume volume38
Publisher Elsevier
Start Page 101669
ISSN 2213-0071
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 The Authors.
File Version publisher
PubMed ID 35646587
DOI 10.1016/j.rmcr.2022.101669
Web of Science KeyUT 001089212200003
Related Url isVersionOf https://doi.org/10.1016/j.rmcr.2022.101669
FullText URL fulltext20231004-03.pdf fig1_20231004-03.pdf fig2_20231004-03.pdf fig3_20231004-03.pdf fig4_20231004-03.pdf fig5_20231004-03.pdf Suppl20231004-03.pdf
Author Kemmotsu, Naoya| Ninomiya, Kiichiro| Kunimasa, Kei| Ishino, Takamasa| Nagasaki, Joji| Otani, Yoshihiro| Michiue, Hiroyuki| Ichihara, Eiki| Ohashi, Kadoaki| Inoue, Takako| Tamiya, Motohiro| Sakai, Kazuko| Ueda, Youki| Dansako, Hiromichi| Nishio, Kazuto| Kiura, Katsuyuki| Date, Isao| Togashi, Yosuke|
Keywords cancer immunotherapy intracranial metastasis intracranial progression memory precursor effector T cell nonsmall-cell lung cancer
Note This is the peer reviewed version of the following article: [Kemmotsu N, Ninomiya K, Kunimasa K, et al. Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies. Int J Cancer. 2024; 154(1): 169-179. doi:10.1002/ijc.34700], which has been published in final form at [https://doi.org/10.1002/ijc.34700]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.| This fulltext file will be available in Aug. 2024.|
Published Date 2023-08-23
Publication Title International Journal of Cancer
Volume volume154
Issue issue1
Publisher Wiley
Start Page 169
End Page 179
ISSN 0020-7136
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 UICC.
File Version author
PubMed ID 37611176
DOI 10.1002/ijc.34700
Web of Science KeyUT 001069876600001
Related Url isVersionOf https://doi.org/10.1002/ijc.34700
FullText URL fulltext.pdf
Author Ando, Chihiro| Ichihara, Eiki| Nishi, Tatsuya| Morita, Ayako| Hara, Naofumi| Takada, Kenji| Nakasuka, Takamasa| Watanabe, Hiromi| Kano, Hirohisa| Nishii, Kazuya| Makimoto, Go| Kondo, Takumi| Ninomiya, Kiichiro| Fujii, Masanori| Kubo, Toshio| Ohashi, Kadoaki| Matsuoka, Ken-Ichi| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki|
Keywords alectinib ALK gilteritinib non-small cell lung cancer TKI
Published Date 2023-09-15
Publication Title Cancer Science
Volume volume114
Issue issue11
Publisher Wiley
Start Page 4343
End Page 4354
ISSN 1347-9032
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 The Authors.
File Version publisher
PubMed ID 37715310
DOI 10.1111/cas.15958
Web of Science KeyUT 001067479000001
Related Url isVersionOf https://doi.org/10.1111/cas.15958
FullText URL fulltext20230421-01.pdf figure20230421-01.pdf
Author Nakasuka, Takamasa| Ohashi, Kadoaki| Nishii, Kazuya| Hirabae, Atsuko| Okawa, Sachi| Tomonobu, Nahoko| Takada, Kenji| Ando, Chihiro| Watanabe, Hiromi| Makimoto, Go| Ninomiya, Kiichiro| Fujii, Masanori| Kubo, Toshio| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Kumon, Hiromi| Maeda, Yoshinobu| Kiura, Katsuyuki|
Keywords EGFR mutation Non-small cell lung cancer Antitumor immunity Non-inflamed tumor Ad-SGE-REIC Gene therapy PD-1
Note ©2023 Elsevier B.V. This manuscript version is made available under the CC-BY-NC-ND 4.0 License. http://creativecommons.org/licenses/by-nc-nd/4.0/. This is the accepted manuscript version. The formal published version is available at https://doi.org/10.1016/j.lungcan.2023.01.018.| This fulltext file will be available in Apr. 2024.|
Published Date 2023-04
Publication Title Lung Cancer
Volume volume178
Publisher Elsevier BV
Start Page 1
End Page 10
ISSN 0169-5002
NCID AA10785743
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 Elsevier B.V.
File Version author
PubMed ID 36753780
DOI 10.1016/j.lungcan.2023.01.018
Web of Science KeyUT 000931976300001
Related Url isVersionOf https://doi.org/10.1016/j.lungcan.2023.01.018
FullText URL fulltext.pdf
Author Makimoto, Go| Shimonishi, Atsushi| Ohashi, Kadoaki| Ninomiya, Kiichiro| Higo, Hisao| Kato, Yuka| Fujii, Masanori| Kubo, Toshio| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki|
Keywords MET Tepotinib Non-small-cell lung cancer
Published Date 2022
Publication Title Case Reports In Oncology
Volume volume15
Issue issue2
Publisher Karger
Start Page 494
End Page 498
ISSN 1662-6575
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 The Author(s).
File Version publisher
PubMed ID 35702678
DOI 10.1159/000524326
Web of Science KeyUT 000864085100005
Related Url isVersionOf https://doi.org/10.1159/000524326
FullText URL fulltext.pdf
Author Ando, Eri| Nakasuka, Takamasa| Kubo, Toshio| Taniguchi, Akihiko| Ninomiya, Kiichiro| Kato, Yuka| Ichihara, Eiki| Ohashi, Kadoaki| Rai, Kammei| Hotta, Katsuyuki| Yamane, Masaomi| Miyahara, Nobuaki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki|
Keywords pulmonary aspergilloma allergic bronchopulmonary aspergillosis disaster
Published Date 2022-02-01
Publication Title Internal Medicine
Volume volume61
Issue issue3
Publisher JAPAN SOC INTERNAL MEDICINE
Start Page 379
End Page 383
ISSN 0918-2918
NCID AA10827774
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 The Japanese Society of Internal Medicine
File Version publisher
PubMed ID 34373373
DOI 10.2169/internalmedicine.7124-21
Web of Science KeyUT 000752787300015
Related Url isVersionOf https://doi.org/10.2169/internalmedicine.7124-21
FullText URL fulltext.pdf
Author Higo, Hisao| Ohashi, Kadoaki| Tomida, Shuta| Okawa, Sachi| Yamamoto, Hiromasa| Sugimoto, Seiichiro| Senoo, Satoru| Makimoto, Go| Ninomiya, Kiichiro| Nakasuka, Takamasa| Nishii, Kazuya| Taniguchi, Akihiko| Kubo, Toshio| Ichihara, Eiki| Hotta, Katsuyuki| Miyahara, Nobuaki| Maeda, Yoshinobu| Toyooka, Shinichi| Kiura, Katsuyuki|
Keywords Idiopathic pulmonary fibrosis RNA sequencing Molecular therapeutic target Personalized therapy
Published Date 2022-02-07
Publication Title Respiratory Research
Volume volume23
Issue issue1
Publisher BMC
Start Page 20
ISSN 1465-993X
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2022.
File Version publisher
PubMed ID 35130915
DOI 10.1186/s12931-022-01940-y
Web of Science KeyUT 000752386100002
Related Url isVersionOf https://doi.org/10.1186/s12931-022-01940-y
FullText URL fulltext.pdf
Author Okawa, Sachi| Rai, Kammei| Fujii, Nobuharu| Gion, Yuka| Ninomiya, Kiichiro| Kato, Yuka| Taniguchi, Akihiko| Kubo, Toshio| Ichihara, Eiki| Ohashi, Kadoaki| Miyahara, Nobuaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki|
Keywords EGFR IgG4-related disease marginal zone lymphoma osimertinib
Published Date 2021-09-01
Publication Title Internal Medicine
Volume volume60
Issue issue17
Publisher The Japanese Society of Internal Medicine
Start Page 2831
End Page 2837
ISSN 0918-2918
NCID AA10827774
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2021 The Japanese Society of Internal Medicine
File Version publisher
PubMed ID 33775999
DOI 10.2169/internalmedicine.6470-20
Web of Science KeyUT 000695856000020
Related Url isVersionOf https://doi.org/10.2169/internalmedicine.6470-20
FullText URL fulltext20210810-3.pdf
Author Nishii, Kazuya| Ohashi, Kadoaki| Watanabe, Hiromi| Makimoto, Go| Nakasuka, Takamasa| Higo, Hisao| Ninomiya, Kiichiro| Kato, Yuka| Kubo, Toshio| Rai, Kammei| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki|
Keywords epidermal growth factor receptor osimertinib bevacizumab cetuximab hypoxia‑inducible factor‑1α transforming growth factor‑α
Published Date 2021-7-7
Publication Title Oncology Letters
Volume volume22
Issue issue3
Publisher Spandidos Publications
Start Page 639
ISSN 1792-1074
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © Nishii et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
File Version publisher
DOI 10.3892/ol.2021.12900
Web of Science KeyUT 000678494600001
Related Url isVersionOf https://doi.org/10.3892/ol.2021.12900
FullText URL fulltext.pdf
Author Watanabe, Hiromi| Ichihara, Eiki| Kayatani, Hiroe| Makimoto, Go| Ninomiya, Kiichiro| Nishii, Kazuya| Higo, Hisao| Ando, Chihiro| Okawa, Sachi| Nakasuka, Takamasa| Kano, Hirohisa| Hara, Naofumi| Hirabae, Atsuko| Kato, Yuka| Ninomiya, Takashi| Kubo, Toshio| Rai, Kammei| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki|
Published Date 2021-01-07
Publication Title Cancer science
Publisher Wiley
ISSN 1347-9032
NCID AA11808050
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2021 The Authors.
File Version publisher
PubMed ID 33410241
NAID 120007008532
DOI 10.1111/cas.14801
Web of Science KeyUT 000630136900001
Related Url isVersionOf https://doi.org/10.1111/cas.14801
FullText URL fulltext.pdf
Author Nishii, Kazuya| Ohashi, Kadoaki| Tamura, Tomoki| Ninomiya, Kiichiro| Matsubara, Takehiro| Senoo, Satoru| Kano, Hirohisa| Watanabe, Hiromi| Oda, Naohiro| Makimoto, Go| Higo, Hisao| Kato, Yuka| Ninomiya, Takashi| Kubo, Toshio| Yamamoto, Hiromasa | Tomida, Shuta| Hotta, Katsuyuki| Tabata, Masahiro| Toyooka, Shinichi| Maeda, Yoshinobu| Kiura, Katsuyuki|
Keywords non-small cell lung cancer epidermal growth factor receptor mutations droplet digital PCR exhaled breath condensate EGFR-TKIs
Published Date 2020-12
Publication Title Oncology Letters
Volume volume20
Issue issue6
Publisher Spandidos Publications
Start Page 393
ISSN 1792-1074
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
File Version publisher
PubMed ID 33193853
DOI 10.3892/ol.2020.12256
Web of Science KeyUT 000595649300005
Related Url isVersionOf https://doi.org/10.3892/ol.2020.12256
JaLCDOI 10.18926/AMO/60796
FullText URL 74_5_371.pdf
Author Makimoto, Go| Ohashi, Kadoaki| Maeda, Yoshinobu| Kiura, Katsuyuki|
Abstract The prognosis of advanced non-small cell lung cancer (NSCLC) patients has improved in recent decades, especially for patients with an oncogenic driver mutation. Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) are effective for patients with the echinoderm microtubule-associated protein-like 4-ALK fusion gene. Several ALK-TKIs have been established: the first-generation ALK-TKI, crizotinib; second-generation ALK-TKIs, alectinib and ceritinib; and third-generation ALK-TKI, lorlatinib. Some ALK-TKIs are effective for tumors that are resistant to other ALK-TKIs; however, as is known in epidermal growth factor receptormutant lung cancer, tumor resistance is inevitable. ALK-positive NSCLCs acquire resistance via various mechanisms, making it a heterogeneous disease. Therefore, it is necessary to develop next-generation treatment strategies, such as the use of next-generation ALK-TKIs for secondary mutations, or combination therapies with ALK-TKIs and other TKIs. In this review, we summarize the development and use of ALK-TKIs, prior pivotal clinical trials, and resistance mechanisms.
Keywords lung cancer anaplastic lymphoma kinase tyrosine kinase inhibitors resistance mechanism
Amo Type Review
Publication Title Acta Medica Okayama
Published Date 2020-10
Volume volume74
Issue issue5
Publisher Okayama University Medical School
Start Page 371
End Page 379
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2020 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 33106692
Web of Science KeyUT 000581970100001
NAID 120006892922